Europe — EMA

Paclitaxel Ebewe

Paclitaxel, the active ingredient in Paclitaxel Ebewe, is a mitotic inhibitor presented as a sterile lyophilized powder for intravenous infusion use.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Ebewe, is a mitotic inhibitor presented as a sterile lyophilized powder for intravenous infusion use. It treats various malignant neoplasms and is administered in oncology settings.

GNH USA supplies Paclitaxel Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Paclitaxel used for?

Paclitaxel is used primarily for solid tumours that follow the micro‑cellular pathway of rapid proliferation. - Breast cancer: Improves the overall response rate when combined with anth‑ c - Ovarian cind ? - Non‑small cell lung ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →